RXO INC
RXONYSE🏆 #1622 by market capEarnings Nov 5US Equity
$20.71▲ $0.58 (+2.78%)
🌙 After hours$20.71▲ 0.00%Regular close · extended-hours price shownTrack RXO
Get earnings, price moves & breaking news on Telegram
24h▲ 2.8%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$3.42B
Small Cap
📈Revenue Growth (YoY)
+26.2%
High Growth
📊Gross Margin
41.6%
Healthy
💵FCF Margin
-0.3%
Thin
⚖️P/S Ratio
0.5x
Cheap
Otter Score
72
Fair
RXO INC
RXOAnalyst Ratings
Price
$20.71
Total
21
Raised
3
Lowered
3
Avg PT
$25.73
H / L
$35 / $18
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Susquehanna | Upgraded | Negative → Neutral | 2026-09-23 | $19.00 | −8.30% |
Wells Fargo | Reiterated | Equal Weight | 2026-09-09 | $23.00 | +11.10% |
Citigroup | Reiterated | Neutral | 2026-08-07 | $33.00 | +59.30% |
Truist Securities | Reiterated | Buy | 2026-08-07 | — | — |
Citizens | Upgraded | Market Perform → Market Outperform | 2026-08-07 | — | — |
UBS | Reiterated | Neutral | 2026-08-07 | $19.00 | −8.30% |
TD Cowen | Reiterated | Sell | 2026-08-07 | — | — |
Goldman Sachs | Reiterated | Neutral | 2026-07-16 | $18.00 | −13.10% |
Stifel | Reiterated | Buy | 2026-07-13 | — | — |
Barclays | Reiterated | Overweight | 2026-06-26 | $28.00 | +35.20% |
Morgan Stanley | Downgraded | Overweight → Equal Weight | 2026-05-08 | $22.00 | +6.20% |
B of A Securities | Reiterated | Neutral | 2026-03-25 | — | — |
Wolfe Research | Upgraded | Underperform → Peer Perform | 2025-11-14 | $15.00 | −27.60% |
JP Morgan | Reiterated | Underweight | 2025-10-08 | — | — |
Jefferies | Reiterated | Buy | 2025-04-11 | $31.00 | +49.70% |
Oppenheimer | Downgraded | Outperform → Perform | 2025-04-04 | $31.00 | +49.70% |
Benchmark | Reiterated | Hold | 2025-01-15 | — | — |
Stephens & Co. | Reiterated | Equal Weight | 2024-05-06 | — | — |
Vertical Research | Downgraded | Buy → Hold | 2024-01-10 | — | — |
Cowen & Co. | Reiterated | Market Perform → Perform | 2023-02-27 | — | — |
Raymond James | Reiterated | Market Perform → Perform | 2022-12-05 | — | — |
Institution
Susquehanna
Upgraded · Negative → Neutral · 2026-09-23
$19.00
−8.30%
Wells Fargo
Reiterated · Equal Weight · 2026-09-09
$23.00
+11.10%
Citigroup
Reiterated · Neutral · 2026-08-07
$33.00
+59.30%
Truist Securities
Reiterated · Buy · 2026-08-07
—
—
Citizens
Upgraded · Market Perform → Market Outperform · 2026-08-07
—
—
UBS
Reiterated · Neutral · 2026-08-07
$19.00
−8.30%
TD Cowen
Reiterated · Sell · 2026-08-07
—
—
Goldman Sachs
Reiterated · Neutral · 2026-07-16
$18.00
−13.10%
Stifel
Reiterated · Buy · 2026-07-13
—
—
Barclays
Reiterated · Overweight · 2026-06-26
$28.00
+35.20%
Morgan Stanley
Downgraded · Overweight → Equal Weight · 2026-05-08
$22.00
+6.20%
B of A Securities
Reiterated · Neutral · 2026-03-25
—
—
Wolfe Research
Upgraded · Underperform → Peer Perform · 2025-11-14
$15.00
−27.60%
JP Morgan
Reiterated · Underweight · 2025-10-08
—
—
Jefferies
Reiterated · Buy · 2025-04-11
$31.00
+49.70%
Oppenheimer
Downgraded · Outperform → Perform · 2025-04-04
$31.00
+49.70%
Benchmark
Reiterated · Hold · 2025-01-15
—
—
Stephens & Co.
Reiterated · Equal Weight · 2024-05-06
—
—
Vertical Research
Downgraded · Buy → Hold · 2024-01-10
—
—
Cowen & Co.
Reiterated · Market Perform → Perform · 2023-02-27
—
—
Raymond James
Reiterated · Market Perform → Perform · 2022-12-05
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space